Investor Relations

Company Overview

BiomX is developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot infections and osteomyelitis. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets.